Professor Axel Behrens elected as Fellow of the Academy of Medical Sciences
Institute of Cancer Research
by
1d ago
Professor Axel Behrens, Scientific Director of the Cancer Research UK Convergence Science Centre and leader of the Cancer Stem Cell Group at The Institute of Cancer Research, London, has been awarded a prestigious Fellowship by the Academy of Medical Sciences ..read more
Visit website
Tracing a new treatment for skin cancer to its roots in ICR science
Institute of Cancer Research
by
1d ago
NICE has approved the skin cancer drug dabrafenib for use on the NHS. Much of the work characterising the function of the mutant protein it targets was carried out at the ICR and here we talk about the story of the research behind BRAF inhibitors ..read more
Visit website
Researchers identify what drives PARP inhibitor resistance in advanced breast cancer
Institute of Cancer Research
by
1w ago
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to more effective ways to treat the disease ..read more
Visit website
Statement in response to NICE approval of dabrafenib for the treatment of certain cases of advanced melanoma
Institute of Cancer Research
by
1w ago
Professor Paul Workman comments on final draft guidance from NICE recommending dabrafenib for the treatment of advanced melanoma which tests positive for the BRAF V600 mutation ..read more
Visit website
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer
Institute of Cancer Research
by
2w ago
Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body ..read more
Visit website
Racing for research – Lucy and Suzie’s stories of running the London Marathon for the ICR
Institute of Cancer Research
by
3w ago
Completing a marathon is no easy feat – but this year two of our #TeamICR runners who took on the London Marathon had been diagnosed and treated for breast cancer in the past five years. They tell us what cancer research means to them ..read more
Visit website
Blood test could identify when cancer treatment has become detrimental
Institute of Cancer Research
by
3w ago
Some treatments for prostate cancer, while initially effective at controlling the disease, not only stop working over time but actually start driving tumour growth, a major new study shows ..read more
Visit website
Science meets art at The London Cancer Hub
Institute of Cancer Research
by
3w ago
The ICR's Public Engagement Manager Mariana Campos reflects on a year of cultural activities at one of London’s most ambitious regeneration projects ..read more
Visit website
ICR researcher wins prestigious clinical science award
Institute of Cancer Research
by
3w ago
Dr Stephen-John Sammut, a Clinician Scientist at the ICR, and Consultant in Medical Oncology at The Royal Marsden, has been awarded the Graham Bull Prize by the Royal College of Physicians for his work in personalised breast cancer medicine ..read more
Visit website
A new era for treating high-risk neuroblastoma – research advances to look out for in 2024
Institute of Cancer Research
by
1M ago
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to further advance this research. We look at some of the latest advances and how they could change the outlook for children with neuroblastoma ..read more
Visit website

Follow Institute of Cancer Research on FeedSpot

Continue with Google
Continue with Apple
OR